Total Payments
$4,386
2024 Payments
$874.09
Companies
27
Transactions
209
Medicare Patients
2,624
Medicare Billing
$400,184
Payment Breakdown by Category
Food & Beverage$4,386 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,386 | 209 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $603.97 | 37 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $545.37 | 19 | $0 (2020) |
| Novo Nordisk Inc | $471.93 | 22 | $0 (2024) |
| Lilly USA, LLC | $422.94 | 16 | $0 (2024) |
| Amarin Pharma Inc. | $411.51 | 12 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $290.85 | 22 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $258.03 | 11 | $0 (2023) |
| GlaxoSmithKline, LLC. | $150.24 | 9 | $0 (2024) |
| Medtronic, Inc. | $120.85 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $116.07 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $874.09 | 35 | Lilly USA, LLC ($290.78) |
| 2023 | $410.57 | 13 | Medtronic, Inc. ($120.85) |
| 2022 | $419.02 | 23 | Lilly USA, LLC ($58.73) |
| 2021 | $338.31 | 21 | Novo Nordisk Inc ($87.62) |
| 2020 | $354.69 | 22 | Amarin Pharma Inc. ($146.36) |
| 2019 | $485.12 | 26 | Amarin Pharma Inc. ($123.56) |
| 2018 | $521.80 | 28 | Amarin Pharma Inc. ($141.59) |
| 2017 | $982.39 | 41 | Novartis Pharmaceuticals Corporation ($388.89) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Biological | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Biological | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $121.64 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: VACCINES | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Biological | ||||||
| 10/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.13 | General |
| 09/27/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $13.60 | General |
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Obesity | ||||||
| 09/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Obesity | ||||||
| 09/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Hepatitis B Vaccine | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: UROLOGY | ||||||
| 07/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Oncology | ||||||
| 06/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Obesity | ||||||
| 04/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 665 | 1,067 | $337,700 | $120,626 |
| 2022 | 9 | 736 | 1,148 | $310,192 | $117,287 |
| 2021 | 6 | 568 | 1,103 | $224,352 | $94,586 |
| 2020 | 9 | 655 | 1,041 | $188,037 | $67,686 |
Total Patients
2,624
Total Services
4,359
Medicare Billing
$400,184
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 404 | 774 | $278,948 | $99,260 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 107 | $27,406 | $9,805 | 35.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 54 | 54 | $23,888 | $7,185 | 30.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 35 | 35 | $3,472 | $2,507 | 72.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 36 | $2,302 | $1,062 | 46.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 32 | $1,088 | $519.04 | 47.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 16 | 16 | $544.00 | $259.20 | 47.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 13 | $52.00 | $28.60 | 55.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 267 | 408 | $147,768 | $59,123 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 270 | 508 | $125,400 | $42,996 | 34.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 43 | 43 | $19,178 | $7,565 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 49 | $8,148 | $2,873 | 35.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 28 | 29 | $3,962 | $1,981 | 50.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 16 | 17 | $1,738 | $863.03 | 49.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 29 | $1,788 | $824.18 | 46.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 24 | 49 | $1,666 | $799.34 | 48.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 14 | 16 | $544.00 | $261.66 | 48.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 295 | 807 | $182,382 | $73,954 | 40.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 49 | 61 | $18,422 | $8,627 | 46.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 73 | $11,388 | $5,343 | 46.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 66 | 66 | $5,544 | $4,299 | 77.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 28 | 28 | $3,080 | $1,244 | 40.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 68 | 68 | $3,536 | $1,119 | 31.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 310 | 657 | $148,365 | $50,350 | 33.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 109 | 134 | $16,972 | $7,166 | 42.2% |
About Dr. Anil Thaker, M.D
Dr. Anil Thaker, M.D is a Geriatric Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982628962.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anil Thaker, M.D has received a total of $4,386 in payments from pharmaceutical and medical device companies, with $874.09 received in 2024. These payments were reported across 209 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,386).
As a Medicare-enrolled provider, Thaker has provided services to 2,624 Medicare beneficiaries, totaling 4,359 services with total Medicare billing of $400,184. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Houston, TX
- Active Since 07/26/2006
- Last Updated 09/20/2024
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1982628962
Products in Payments
- ENTRESTO (Drug) $545.37
- Vascepa (Drug) $411.51
- MOUNJARO (Drug) $330.66
- FARXIGA (Drug) $225.56
- XARELTO (Drug) $224.57
- Myrbetriq (Drug) $202.29
- Ozempic (Drug) $194.72
- MYRBETRIQ (Drug) $192.65
- Wegovy (Drug) $154.55
- HAWKONE (Device) $120.85
- VESICARE (Drug) $112.79
- Cologuard Collection Kit (Device) $110.89
- JARDIANCE (Drug) $110.36
- Veozah (Drug) $96.24
- VRAYLAR (Drug) $76.68
- GEMTESA (Drug) $72.07
- INVOKANA (Drug) $66.28
- Heplisav-B (Drug) $61.23
- SHINGRIX (Biological) $59.95
- Doc Band (Device) $55.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Houston
Dr. Aimee Garcia, M.d, M.D
Geriatric Medicine — Payments: $11,542
Geriatric Medicine $11,542
George Taffet, Md, MD
Geriatric Medicine — Payments: $8,918
Geriatric Medicine $8,918
Radhika Hariharan, Md, MD
Geriatric Medicine — Payments: $3,502
Geriatric Medicine $3,502
Dr. Jerome Wasserstein, D.o, D.O
Geriatric Medicine — Payments: $3,231
Geriatric Medicine $3,231
Dr. Elenita Rosado, M.d, M.D
Geriatric Medicine — Payments: $3,054
Geriatric Medicine $3,054
Sistla Krishna, M.d, M.D
Geriatric Medicine — Payments: $2,766
Geriatric Medicine $2,766